Phosphodiesterase type 5 (PDE5) inhibitors have reduced efficacy in treating erectile dysfunction (ED) in conditions where there is a lack of endogenous nitric oxide (NO). Therefore, NO-releasing PDE5 inhibitors have been developed. Here we report the effect of such a compound, NCX-911, on the tone and nitrergic relaxations of rabbit corpus cavernosum in the absence or presence of a NO synthase inhibitor, N G -nitro-L-arginine methyl ester (L-NAME; 500 lM). NCX-911 was found to be as potent as sildenafil at inducing relaxation of rabbit cavernosum (EC 50 values 997.87195.7 and 1000.57140.8 nM, respectively). The potency of NCX-911 was not altered, but that of sildenafil decreased five-fold in the presence of L-NAME (EC 50 values 1281.27268.3 and 4959.17882.1, nM respectively, Po0.001 for sildenafil). Both compounds potentiated nitrergic relaxations with similar potencies. These results suggest that NO-releasing PDE5 inhibitors could potentially be more useful than PDE5 inhibitors in the treatment of ED in conditions where there is a lack of endogenous NO.
Introduction
Male erectile dysfunction (MED) is a significant male health problem reported to affect the lives of 35-54% of men aged over 40 y. 1 The management of MED was revolutionized with the introduction of the first oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil (Viagra s ) in 1998. 2 Viagra has been found to be highly effective in a wide range of patient subtypes; however, certain groups of patients such as long-term diabetics and postradical prostatectomy patients do not gain the same degree of benefit. [3] [4] [5] This has been postulated to be due to a lack of endogenous nitric oxide (NO) production. 6, 7 Two further PDE5 inhibitors (tadalafil Cialis s , vardenafil Levitra s ) have recently been launched. Clinical trials have demonstrated that both agents are also effective in a wide range of patient subtypes; 8, 9 however, they too are less effective in diabetic and postradical prostatectomy patients. 10, 11 Therefore new therapeutic options, which do not require endogenous NO, are being developed. One such approach is an NO-releasing derivative of sildenafil (sildenafil nitrate; NCX-911) as a potential medical therapy for MED.
NCX-911 and sildenafil have a similar selectivity and potency with respect to inhibiting PDE5. 12 However unlike sildenafil, NCX-911 has been shown to release NO spontaneously and increase cGMP concentrations by activating soluble guanylate cyclase (sGC) and inhibiting PDE5. 12, 13 Furthermore, NCX-911 has been shown to increase cGMP in a concentration-dependent manner in the absence of endogenous NO, whereas sildenafil has little effect on cGMP concentrations under the same conditions. 12 In a hypercholesterolaemic rabbit model, NCX-911 was shown to be 5-10 times more potent than sildenafil at reducing the phenylephrineinduced tone.
The aim of this study was to investigate the effect of NCX-911 on the tone and nitrergic responses of rabbit corpus cavernosum and compare the effects with that of sildenafil and an NO donor (spermineNONOate) in the absence or presence of a NOS inhibitor.
Materials and methods

Rabbit corpus cavernosum
Male New Zealand White rabbits (3.0-3.5 kg, Harlan, UK) were killed by an overdose of phentobarbitone (Euthesate, Willows Francis Veterinary, UK) injected into the marginal vein of the ear. The penis was excised from pubic bone. The tunica albuginea around the corpus cavernosum was cut open. The corpus cavernosum was excised and cut longitudinally to obtain four identical strips (4 Â 10 mm). All animal experiments were conducted according to the rules outlined by the Home Office, Animals (Scientific Procedures) Act 1986.
Mounting the tissues and recording the mechanical responses
Each preparation was cleaned of adherent tissues and mounted horizontally between two ring electrodes (4 mm diameter) in superfusion chambers (371C) as described previously. 14, 15 The chambers were perfused with modified Krebs' solution at a constant flow of 1.0 ml/min by means of peristaltic pumps (Miniplus 2, Gilson). One end of the preparation was tied to a Grass FT 03C force-displacement transducer connected to a Linearcorder WR 3101 (Graphtec, Tokyo, Japan) for registration of isometric changes in tension. The preparations were given a tension (0.4-1 g) and allowed to equilibrate for 90 min. The preparations were stimulated electrically (electrical field stimulation; EFS) for 5 s with trains of rectangular pulses of 50 V, 0.3 ms pulse duration and at a range of frequency of 0.5-25 Hz, delivered by Grass S88 stimulators. The recorder was run at a rate of 25 mm/min to record the mechanical responses. The mechanical responses were also recorded on a computer by a specialized data acquisition system (Axon Instruments, USA).
Chemicals and solutions
The composition of the modified Krebs' solution was (mM): NaCl 136.9, KCl 2.7, CaCl 2 1.8, MgSO 4 0.6, NaHCO 3 11.9, KH 2 PO 4 0.5, glucose 11.5, indomethacin 0.01, dexamethasone 0.01, and gassed with 5% CO 2 in O 2 (pH 7.0-7.2). The inducible form of NOS (iNOS) can be induced by trace amounts of endotoxin in the buffer 16 and cause loss of tone. 17 Dexamethasone was added to the modified Krebs' solution to prevent induction of iNOS. 16 The cyclooxygenase inhibitor indomethacin was added to prevent synthesis of prostaglandins since these can cause non-neurogenic relaxations. 18 In our experiments, we used spermine-NONOate which is a spontaneous NO donor, which does not require cofactors or catalysts to release NO in a physiological solution. 19 Dexamethasone, guanethidine monosulfate, indomethacin, N G -nitro-L-arginine methyl ester (L-NAME) and scopolamine hydrochloride were obtained from Sigma, UK. Spermine-NONOate and tetrodotoxin were obtained from Calbiochem, UK. NCX-911 was provided by Nicox SA (Sophia Antipolis, France). Sildenafil citrate was extracted from Viagra s tablets as the free base, analysed by 1H-NMR and LC/MS to confirm identity and purity (497%) and then converted to its citrate salt by Dr D Madge at the Medicinal Chemistry Department, Wolfson Institute for Biomedical Research, University College London. Chemical structures of NCX-911 and sildenafil citrate are presented in Figure 1 . Drugs were applied directly to the medium reservoir.
Statistical analysis and presentation of the results
The effect of drugs on phenylephrine-induced tone was expressed as the percentage of the height of contraction of the same tissue under control conditions. The effect of drugs on EFS-induced relaxation responses was calculated as percentage of area under the relaxation curve (AUC) of the same tissue under control conditions. EC 50 values were calculated using Microcal Origin software (Version 4.1). Results are expressed as mean7s.e. of the mean. Statistical analysis was performed using Student's unpaired two-tailed t-test. A probability value (P) less than 0.05 was considered to be statistically significant. n denotes the number of animals used for each set of experiments. Effect of NCX-911 on rabbit corpus cavernosum JS Kalsi et al
Results
Effect of NCX-911 on phenylephrine-induced tone
After treatment of the tissues with scopolamine (10 mM) and guanethidine (10 mM) to inhibit cholinergic and noradrenergic pathways, respectively, and elevation of tone with phenylephrine (3 mM, EC 80 ), administration of NCX-911 into the superfusion fluid resulted in a complete relaxation of rabbit cavernosal strips in a concentration-dependent manner (EC 50 ¼ 997. 87195.7 nM) ( Figure 2 and Table 1 ). The NO synthase inhibitor L-NAME (500 mM) resulted in a slight but nonsignificant rightward parallel shift in the concentration response curve to NCX-911; in the presence of 500 mM L-NAME, EC 50 of NCX-911 was 1281.27268.3 nM (P ¼ 0.41 vs control) ( Figure 2 and Table 1 ).
Effect of sildenafil on phenylephrine-induced tone
Sildenafil caused relaxation of rabbit cavernosal strips in a concentration-dependent manner (EC 50 ¼ 1000.57140.8 nM). The addition of L-NAME (500 mM) resulted in a significant rightward parallel shift in the concentration response curve to sildenafil. EC 50 of sildenafil was 4959.17882.1 nM in the presence of 500 mM L-NAME (Po0.05 vs control) ( Figure 3 and Table 1 ).
Effect of spermine-NONOate on phenylephrineinduced tone
Spermine-NONOate elicited concentration-dependent relaxation of rabbit cavernosal strips (EC 50 ¼ 843.3754.4 nM). In the presence of L-NAME (500 mM), the potency of spermine-NONOate was not changed (EC 50 ¼ 698.42761.86 nM; P ¼ 0.1002) ( Figure 4 and Table 1 ).
Eliciting nitrergic relaxations
EFS (50 V, 0.3 ms pulse duration, 0.5-25 Hz, for 5 s, every 120 s) elicited reproducible contractions of the tissues. After treatment of the tissues with scopolamine (10 mM) and guanethidine (10 mM) and Figure 2 The effect of NCX-911 (0.01-30 mM) on phenylephrineinduced tone in the rabbit corpus cavernosum in the absence (squares) or presence of L-NAME (500 mM; triangles). n denotes the number of animals used for each set of experiments. *Po0.05 vs sildenafil in the absence of L-NAME. Figure 3 The effect of sildenafil (0.001-30 mM) on phenylephrine-induced tone in the rabbit corpus cavernosum in the absence (squares) or presence of L-NAME (500 mM; triangles).
Figure 4
The effect of spermine-NONOate (0.001-30 mM) on phenylephrine-induced tone in the rabbit corpus cavernosum in the absence (squares) or presence of L-NAME (500 mM; triangles).
Effect of NCX-911 on rabbit corpus cavernosum JS Kalsi et al elevation of tone with phenylephrine (3 mM, EC 80 ), EFS elicited reproducible frequency-dependent relaxation responses with an optimum frequency of 5 Hz (not shown). These relaxations were completely inhibited with an inhibitor of sGC, ODQ (30 mM), an inhibitor of NO synthase, L-NAME (500 mM) or tetrodotoxin (1 mM) indicating that they were nitrergic in nature and neurogenic in origin (not shown).
Effect of NCX-911 on nitrergic relaxations
Since above 100 nM NCX-911 was able to reduce the phenylephrine-induced tone and it is not possible to elucidate the nitrergic relaxation responses at reduced tone, two concentrations (10 and 30 nM) were chosen to study the effect of the drug on nitrergic responses. At those subthreshold concentrations, NCX-911 potentiated both the duration and magnitude of the relaxation responses (Figures 5a  and 6 ; 10 nM not shown).
Effect of sildenafil on nitrergic relaxations
At subthreshold concentrations of sildenafil (10 and 30 nM), the duration and magnitude of the nitrergic relaxation responses were potentiated (Figures 5b  and 6 ; 10 nM not shown). Sildenafil citrate and NCX-911 had similar potency to enhance nitrergic relaxations at all frequencies ( Figures 5 and 6 ).
Effect of sildenafil and NCX-911 on blocked nitrergic responses
After the nitrergic relaxations were blocked by L-NAME (500 mM), administration of sildenafil and NCX-911 decreased the phenylephrine-induced tone as mentioned above; however, nitrergic responses were not observed to appear again ( Figure 7 ).
Discussion
Relaxation of penile cavernosal and vascular smooth muscle is the most important step in penile erection. 20 NO is now accepted to have a fundamental role in this process. It has been shown to induce an increased production of the second messenger cGMP via stimulation of the enzyme sGC in the penile smooth muscle. In turn, cGMP has been shown to activate a number of downstream systems, ultimately resulting in relaxation of the cavernosal smooth muscle. Hz, for 5 s, every 120 s) elicited nitrergic responses that were completely inhibited by L-NAME (500 mM). NCX-911 or sildenafil lowered the tone of the tissue with different potencies in the presence of L-NAME; however, they failed to reverse the inhibition of the nitrergic responses.
Effect of NCX-911 on rabbit corpus cavernosum JS Kalsi et al PDE5 inhibitors such as sildenafil, tadalafil and vardenafil have been very successful in the management of erectile dysfunction. They improve erectile function by reducing the breakdown of the active cGMP and thereby potentiating its action. However, diabetic patients 5, 10, 11 and patients with cavernosal nerve injury following radical prostatectomy 4 have had less success with PDE5 inhibitors than other patient groups. It has been proposed that this is the result of a lack of endogenous NO production. 6, 7, 22 It has been postulated that in order for a PDE5 to be successful, a certain degree of residual NO must be present. 23 In order to address this problem, novel agents that are combinations of a PDE5 inhibitor and NOreleasing compounds have been produced. NCX-911 (sildenafil nitrate) is one such agent.
In this study, we have shown that NCX-911 lowers the phenylephrine-induced tone in rabbit corpus cavernosum with an EC 50 of approximately 990 nM. This is in agreement with a previous study where the EC 50 of the compound to relax human corpus cavernosum was in the range of 1-10 mM. 13 In our study, the potency of NCX-911 on lowering phenylephrine-induced tone was similar to both sildenafil and the NO donor in control tissues. However, after addition of the NOS inhibitor the potencies of both NCX-911 and NO donor remained unchanged, whereas that of sildenafil was decreased five-fold. These results suggest that NCX-911 and NO donors do not require endogenous NO to relax cavernosal smooth muscle. Sildenafil, however, seems to be relatively dependent on endogenous NO to elicit its relaxant action.
These results are in accordance with a previous study where endogenous NO production was reduced in a hypercholesterolaemic rabbit model and NCX-911 was 5-10 times more potent than sildenafil citrate in reducing phenylephrine-induced tension. 12 Furthermore, in anaesthetized rats, the cavernous nerve-stimulation-induced increase in intracavernous pressure was enhanced by intravenous administration of both sildenafil and NCX-911; however, at submaximal stimulation NCX-911 was more potent than sildenafil. 12 Similarly in streptozotocin-induced diabetic rats, NCX-911 has been found to be more potent than sildenafil citrate (JS Kalsi, PD Kell, DJ Ralph and S Cellek, unpublished observations).
Both NCX-911 and sildenafil increased the magnitude and the duration of nitrergic relaxations with similar potencies in the rabbit corpus cavernosum. These results suggest that both compounds have similar mechanisms of action and properties under control conditions despite the differences in chemical structure. Release of the NO from the NCX-911 compound does not seem to further potentiate the nitrergic relaxations in normal rabbit corpus cavernosum.
However, it is uncertain whether NCX-911 will have the same potency in vivo to potentiate penile erection and/or the same capacity to donate NO as it has in vitro. Further in vivo studies are required to address these issues.
In the presence of an inhibitor of NO synthase, the nitrergic relaxations were completely inhibited in the rabbit corpus cavernosum. Increasing concentrations of NCX-911 or sildenafil were not able to reverse the loss of nitrergic relaxations. This is in contrast to the effect of an NO-independent sGC activator, BAY41-2272. 15 This agent has been reported to be able reverse the loss of nitrergic relaxation at concentrations greater than 300 nM. 15 BAY-41 2272 has been shown to bind to an allosteric site on the sGC enzyme different to the binding site for NO. 24 Binding at the allosteric site may lead to a conformational change such that there is an increased affinity for NO. The conformational change may be responsible for the reversal of inhibition of nitrergic relaxations. In contrast, there are no reported conformational changes associated with the addition of either a PDE5 inhibitor or an NO donor.
In conclusion, our results suggest that NCX-911 is a potent relaxant of rabbit cavernosal smooth muscle with a similar potency to NO. It is equally efficacious with respect to relaxation of rabbit corpus cavernosum independent of NO availability. Like PDE5 inhibitors, NCX-911 potentiates both the duration and the magnitude of the nitrergic relaxation. Therefore, NCX-911 may be a novel way of treating MED particularly in patients where endogenous NO production is dysfunctional.
